10x Genomics(TXG) - 2026 Q1 - Quarterly Results
Exhibit 99.1 Recent Updates "We had a solid start to the year, with double-digit growth in Single Cell consumables reaction volumes and double-digit growth in Spatial consumables revenue," said Serge Saxonov, Co-founder and CEO of 10x Genomics. "The biggest highlight is our recent launch of Atera, which represents the most significant product introduction in our history. We are extremely encouraged by the extraordinary early customer response." First Quarter 2026 Financial Results Revenue was $150.8 million ...